Tangningtongluo Tablet for People With Prediabetes
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 240 participants.
Also called NCT05126251
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 240 participants
- Registry
-
NCT05126251
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT05126251. Randomized; triple masking; primary purpose treatment. Start 2021-12-13 (actual); primary completion 2022-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Tangningtongluo Tablet for People With Prediabetes
- Condition
- Prediabetes
- Intervention (Drug)
- Tangningtongluo tablet
- Intervention (Behavioral)
- lifestyle intervention
- Lead sponsor
- Beijing University of Chinese Medicine
Record details
- Record id
cardio:ct-nct05126251- Content hash
36f317e96e798934459b5c54c254c39bb3bba56fa6433db6e441fd38f179f024